Phase 1 Donor Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

Acute Leukemia, High RiskMyelodysplastic Syndromes, High RiskHematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor

Ciusss de L'Est de l'Île de Montréal7 enrolled1 locationNCT07301866

Terminated

Phase 1

Haploidentical stem cell transplantation with iCasp9 T cell addback in patients with poor risk haematological malignancies

Patients with high risk acute leukaemia, myelodysplastic syndrome or chronic myeloid leukaemia, who lack a suitable fully human leukocyte antigen (HLA)-matched or single-antigen mismatched donor.

Metro North Hospital and Health Service - Royal Brisbane and Womens’ Hospital12 enrolled1 locationACTRN12614000290695